Analysts Cut Ratings and Price Targets for US-Listed Companies
Wall Street analysts lowered ratings and price targets for several US-listed companies, including Amgen, CarMax and Pfizer.
Wall Street analysts lowered ratings and price targets for several US-listed companies, including Amgen, CarMax and Pfizer.